These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7655514)

  • 1. Disruption of the adenosine deaminase (ADA) gene using a dicistronic promoterless construct: production of an ADA-deficient homozygote ES cell line.
    Vaulont S; Daines S; Evans M
    Transgenic Res; 1995 Jul; 4(4):247-55. PubMed ID: 7655514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.
    Bradford KL; Moretti FA; Carbonaro-Sarracino DA; Gaspar HB; Kohn DB
    J Clin Immunol; 2017 Oct; 37(7):626-637. PubMed ID: 28842866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
    Bordignon C; Mavilio F; Ferrari G; Servida P; Ugazio AG; Notarangelo LD; Gilboa E; Rossini S; O'Reilly RJ; Smith CA
    Hum Gene Ther; 1993 Aug; 4(4):513-20. PubMed ID: 8399494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of murine adenosine deaminase in the gastrointestinal tract.
    Xu PA; Kellems RE
    Biochem Biophys Res Commun; 2000 Mar; 269(3):749-57. PubMed ID: 10720488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
    Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
    Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine deaminase deficiency due to heterozygous abnormality consisting of a deletion of exon 7 and the absence of enzyme mRNA.
    Kashii S; Ito K; Monden S; Sasai Y; Tsuchida K; Fujita M; Kawamoto H; Norioka M; Okuma M
    J Cell Biochem; 1991 Sep; 47(1):49-53. PubMed ID: 1939366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.
    Hirschhorn R; Tzall S; Ellenbogen A; Orkin SH
    J Clin Invest; 1989 Feb; 83(2):497-501. PubMed ID: 2783588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.
    Silver JN; Flotte TR
    Pharmacogenomics; 2008 Jul; 9(7):947-68. PubMed ID: 18597656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.
    Arredondo-Vega FX; Santisteban I; Kelly S; Schlossman CM; Umetsu DT; Hershfield MS
    Am J Hum Genet; 1994 May; 54(5):820-30. PubMed ID: 8178821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus.
    Kim DG; Kang HM; Jang SK; Shin HS
    Mol Cell Biol; 1992 Aug; 12(8):3636-43. PubMed ID: 1321342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
    Belmont JW; Henkel-Tigges J; Chang SM; Wager-Smith K; Kellems RE; Dick JE; Magli MC; Phillips RA; Bernstein A; Caskey CT
    Nature; 1986 Jul 24-30; 322(6077):385-7. PubMed ID: 3016551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of normal and mutant forms of human adenosine deaminase - a review.
    Daddona PE; Kelley WN
    Mol Cell Biochem; 1980 Feb; 29(2):91-101. PubMed ID: 6988697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects.
    Mortellaro A; Hernandez RJ; Guerrini MM; Carlucci F; Tabucchi A; Ponzoni M; Sanvito F; Doglioni C; Di Serio C; Biasco L; Follenzi A; Naldini L; Bordignon C; Roncarolo MG; Aiuti A
    Blood; 2006 Nov; 108(9):2979-88. PubMed ID: 16835374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
    Ferrari G; Rossini S; Giavazzi R; Maggioni D; Nobili N; Soldati M; Ungers G; Mavilio F; Gilboa E; Bordignon C
    Science; 1991 Mar; 251(4999):1363-6. PubMed ID: 1848369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death.
    Migchielsen AA; Breuer ML; van Roon MA; te Riele H; Zurcher C; Ossendorp F; Toutain S; Hershfield MS; Berns A; Valerio D
    Nat Genet; 1995 Jul; 10(3):279-87. PubMed ID: 7670465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new strategy of gene trapping in ES cells using 3'RACE.
    Yoshida M; Yagi T; Furuta Y; Takayanagi K; Kominami R; Takeda N; Tokunaga T; Chiba J; Ikawa Y; Aizawa S
    Transgenic Res; 1995 Jul; 4(4):277-87. PubMed ID: 7655516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
    Adrian GS; Hutton JJ
    J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow gene therapy for adenosine deaminase deficiency.
    Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
    Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.